abstract |
The subject of the invention is a pharmaceutical, especially dermatological, composition comprising laropiprant, an ester or a pharmaceutically acceptable salt thereof, and oxymetazoline or a pharmaceutically acceptable salt thereof and its use for treating dermatological conditions, including rosacea. |